TIBCO Spotfire and INTEGROMICS Announce Genomics Data Analysis Solution to Speed Drug Research and Development
Product News Sep 24, 2008
TIBCO Software Inc. together with INTEGROMICS announced a solution for genomics research that provides researchers and scientists with a direct, interactive, visual approach to data analysis that reveals insights and unexpected relationships in genomics data.
Genomics technologies - used by pharmaceutical R&D departments to understand disease biology and drug response in order to develop new and better drugs - are now used across the entire drug development process to better understand disease biology, mechanisms of drug action, mechanisms of toxicity, and individuals and their response to a drug.
Genomics-based biomarkers are dramatically impacting drug development by providing more precise diagnoses of disease states and drug response in individual patients. The software used to analyze and explore genomic data had not kept pace with the advancing genomics research.
Spotfire and INTEGROMICS, however, joined forces to address the needs of modern genomics research in areas including biomarker research, translational medicine, and systems biology by introducing INTEGROMICS Biomarker Discovery for TIBCO Spotfire®.
The scientific and workflow knowledge of INTEGROMICS, combined with the adaptability and ease of use of the TIBCO Spotfire platform, provide researchers with a powerful genomic data analysis environment. The new solution enables pharmaceutical, biotechnology, and academic research groups to find and categorize complex patterns.